KYNB Earnings KYNTRA BIO, INC.
Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Latest filing
Annual results
EPS
Revenue
Net income
Quarterly results
EPS
Revenue
Net income
Reported EPS history
1–36 of 36
| Q2 2026 | 2026-06-30 | 2.96 | 2026-08-13 | 10-Q |
| Q1 2026 | 2026-03-31 | -3.76 | 2026-05-12 | 10-Q |
| Q4 2025 (derived) | 2025-12-31 | -3.51 | 2026-03-16 | 10-K |
| FY 2025 | 2025-12-31 | 45.37 | 2026-03-16 | 10-K |
| Q3 2025 | 2025-09-30 | 49.61 | 2025-11-10 | 10-Q |
| Q2 2025 | 2025-06-30 | -1.88 | 2025-08-11 | 10-Q |
| Q1 2025 | 2025-03-31 | 1.15 | 2025-05-12 | 10-Q |
| Q4 2024 (derived) | 2024-12-31 | 4.50 | 2025-03-17 | 10-K |
| FY 2024 | 2024-12-31 | -11.89 | 2025-03-17 | 10-K |
| Q3 2024 | 2024-09-30 | -4.25 | 2024-11-12 | 10-Q |
| Q2 2024 | 2024-06-30 | -3.89 | 2024-08-06 | 10-Q |
| Q1 2024 | 2024-03-31 | -8.25 | 2024-05-06 | 10-Q |
| Q4 2023 (derived) | 2023-12-31 | -14.00 | 2024-02-26 | 10-K |
| FY 2023 | 2023-12-31 | -73.00 | 2024-02-26 | 10-K |
| Q3 2023 | 2023-09-30 | -16.25 | 2023-11-06 | 10-Q |
| Q2 2023 | 2023-06-30 | -22.50 | 2023-08-07 | 10-Q |
| Q1 2023 | 2023-03-31 | -20.25 | 2023-05-08 | 10-Q |
| Q4 2022 (derived) | 2022-12-31 | -17.50 | 2023-02-27 | 10-K |
| FY 2022 | 2022-12-31 | -78.50 | 2023-02-27 | 10-K |
| Q3 2022 | 2022-09-30 | -24.50 | 2022-11-07 | 10-Q |
| Q2 2022 | 2022-06-30 | -19.50 | 2022-08-08 | 10-Q |
| Q1 2022 | 2022-03-31 | -17.00 | — | — |
| FY 2021 | 2021-12-31 | -78.50 | — | — |
| Q3 2021 | 2021-09-30 | 13.50 | 2021-11-09 | 10-Q |
| Q2 2021 | 2021-06-30 | -36.25 | — | — |
| FY 2020 | 2020-12-31 | -52.75 | — | — |
| Q3 2019 | 2020-09-30 | 8.75 | 2020-11-05 | 10-Q |
| Q2 2019 | 2020-06-30 | -23.75 | 2020-08-06 | 10-Q |
| Q3 2019 | 2019-09-30 | -14.25 | 2019-11-12 | 10-Q |
| Q2 2019 | 2019-06-30 | 31.50 | 2019-08-08 | 10-Q |
| Q3 2018 | 2018-09-30 | -12.50 | — | — |
| Q2 2018 | 2018-06-30 | -7.00 | — | — |
| Q2 2017 | 2017-06-30 | -12.00 | 2017-08-07 | 10-Q |
| Q2 2016 | 2016-06-30 | 8.75 | 2016-08-08 | 10-Q |
| Q2 2015 | 2015-06-30 | 20.75 | 2015-08-13 | 10-Q |
| Q2 2014 | 2014-06-30 | 14.50 | — | — |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Q4 EPS marked "derived" is computed as the fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive across quarters, so it can differ by a cent or two from the issuer's own Q4. A period with no "Reported" date is known only from a later filing's prior-year comparative. Informational only — not financial advice.